Stealth BioTherapeutics Announces Delay in FDA Action Date for  Barth Syndrome Application
Hand-out
Press Releases
STEALTH BIOTHERAPEUTICS INC.  
April 29, 2025

Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application

- FDA decision on elamipretide for the treatment of Barth syndrome delayed -

logo salamanca press

Salamanca Press

Local & Social